{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:07:01Z","timestamp":1761581221538},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T00:00:00Z","timestamp":1426118400000},"content-version":"vor","delay-in-days":192,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1002\/nmi2.57","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T02:38:59Z","timestamp":1407119939000},"page":"150-153","source":"Crossref","is-referenced-by-count":8,"title":["First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009\u20132013"],"prefix":"10.1016","volume":"2","author":[{"given":"D.","family":"Golparian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Brilene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Laaring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Viktorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Domeika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/nmi2.57_bib1","series-title":"Global incidence and prevalence of selected curable sexually transmitted infections \u2013 2008","author":"World Health Organization","year":"2012"},{"key":"10.1002\/nmi2.57_bib2","series-title":"Sexually transmitted infections in Europe 2011","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"10.1002\/nmi2.57_bib3","unstructured":"Sexually Transmitted Diseases Treatment Guidelines, 2011. In Estonian."},{"key":"10.1002\/nmi2.57_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1002\/nmi2.57_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1002\/nmi2.57_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","article-title":"Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods","volume":"58","author":"Tapsall","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1002\/nmi2.57_bib7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea, Australia","volume":"68","author":"Chen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/nmi2.57_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1071\/SH13077","article-title":"One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia","volume":"10","author":"Read","year":"2013","journal-title":"Sex Health"},{"key":"10.1002\/nmi2.57_bib9","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/nmi2.57_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/nmi2.57_bib11","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain","volume":"67","author":"C\u00e1mara","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/nmi2.57_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2334-14-65","article-title":"Antimicrobial susceptibility\/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010\u20132012","volume":"14","author":"Mlynarczyk-Bonikowska","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1002\/nmi2.57_bib13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes","volume":"63","author":"Unemo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/nmi2.57_bib14","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/383047","article-title":"Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area","volume":"189","author":"Martin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1002\/nmi2.57_bib15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/jac\/dku026","article-title":"Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006\u201312: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?","volume":"69","author":"Jeverica","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/nmi2.57_bib16","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1128\/JCM.01236-09","article-title":"First Neisseria gonorrhoeae genotyping analysis in France: identification of a strain cluster with reduced susceptibility to ceftriaxone","volume":"47","author":"Monfort","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1002\/nmi2.57_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1469-0691.2008.02071.x","article-title":"Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network","volume":"14","author":"Starnino","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/nmi2.57_bib18","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1128\/AAC.05481-11","article-title":"Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands","volume":"56","author":"Heymans","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/nmi2.57_bib19","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.03.20358-en","article-title":"Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone","volume":"18","author":"Chisholm","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1002\/nmi2.57_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkp505","article-title":"Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone","volume":"65","author":"Lee","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/nmi2.57_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sti.2010.045377","article-title":"Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden","volume":"86","author":"Golparian","year":"2010","journal-title":"Sex Transm Infect"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297514500376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297514500376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T14:41:28Z","timestamp":1649860888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297514500376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2052297514500376"],"URL":"https:\/\/doi.org\/10.1002\/nmi2.57","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}